investment

News

Report says US biotech needs $15bn support to fend off China

The US is close to falling behind China in biotech and the government should spend a minimum of $15bn over the next five years to support the sector.

News

Chiesi backs growth plans with a €430m new plant in Italy

Fast-growing pharma group Chiesi has revealed plans to spend €430m on a new therapeutics manufacturing facility at its site in Milan.

News

Building site with thre emen in high viz jackets and protective headweare

AZ builds in China, as J&J ramps up its US investments

AstraZeneca will open its sixth R&D centre in China, while J&J announces four new manufacturing facilities in the US in a major reshoring drive.

News

UK is becoming an 'outlier' for pharma, hitting investment

UK pharma leaders have renewed calls for a rethink by the government on levies imposed on medicine sales, saying investment is already being hit.

News

man in protective gear at manufacturing facility

MSD opens $1bn plant for HPV vaccine in the US

MSD has opened the doors of a $1bn facility at its site in Durham, North Carolina, that will be used to produce its HPV vaccine Gardasil.

R&D

On incentivisation and investment in rare disease R&D

To mark Rare Disease Day, pharmaphorum spoke with Paola Pozzi, partner of telethon strategy at Sofinnova Partners, about the outlook for investment in this field of research.

Report says US biotech needs $15bn support to fend off China

Chiesi backs growth plans with a €430m new plant in Italy

AZ builds in China, as J&J ramps up its US investments

UK is becoming an 'outlier' for pharma, hitting investment

MSD opens $1bn plant for HPV vaccine in the US

On incentivisation and investment in rare disease R&D

LSX2026: On a therapeutic vision for ocular disease, with Al...

Using AI-driven synthetic personas to take your insights fur...

investment

Editor's Picks